nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addressing Gaps in Management of Homozygous Familial Hypercholesterolemia: The Impacts of Continuing Medical Education that Includes Patients
|
Drexel, Carole |
|
|
17 |
4S |
p. e3 |
artikel |
2 |
⁎ A Genome-First Approach to Identify Carriers of Familial Hypercholesterolemia Causing variants
|
Mami, Salma |
|
|
17 |
4S |
p. e24-e25 |
artikel |
3 |
A Machine-Learning Algorithm using Claims Data to Identify Patients with Homozygous Familial Hypercholesterolemia (HoFH)
|
Gu, Jing |
|
|
17 |
4S |
p. e24 |
artikel |
4 |
† Angiographic Outcomes When Target Goals of Lipid Therapy Are Not Met
|
Feeman Jr, William E. |
|
|
17 |
4S |
p. e11-e12 |
artikel |
5 |
† A Randomized Study to Compare LDL-C-Lowering Effects of Inclisiran with Usual Care vs Usual Care Alone in Patients with Recent Hospitalization for an Acute Coronary Syndrome: Rationale and Design of the VICTORION-INCEPTION trial
|
Anderson, Jeffrey L |
|
|
17 |
4S |
p. e55-e56 |
artikel |
6 |
A Rare Dyslipidemia: Review of Diagnosis and Therapeutics in Management of Familial Chylomicronemia Syndrome (FCS)
|
Javed, Fiza |
|
|
17 |
4S |
p. e53-e54 |
artikel |
7 |
Association between Niacin ER Use, Safety, and Cardiovascular Events: A Single Center Experience
|
Tabani, Halima Mushtaq |
|
|
17 |
4S |
p. e48-e49 |
artikel |
8 |
Association of Physical Activity and Dietary Quality with Weight, Ectopic Fat, and Insulin Resistance in South Asian Men and Women: The MASALA Study
|
Ponir, Cynthia Azam |
|
|
17 |
4S |
p. e49-e50 |
artikel |
9 |
Atrial Fibrillation Outcome in Patients with Familiar Hypercholesterolemia
|
Amoah, Joseph Kofi |
|
|
17 |
4S |
p. e30-e31 |
artikel |
10 |
Bempedoic Acid and Cardiovascular Outcomes in Statin Intolerant Patients At High Cardiovascular Risk: CLEAR OUTCOME
|
Cho, Leslie |
|
|
17 |
4S |
p. e62 |
artikel |
11 |
Beneficial Effect of Statins in Chronic Kidney Disease
|
Vorla, Mounica |
|
|
17 |
4S |
p. e39-e40 |
artikel |
12 |
CAC Scoring as an Index for Subclinical Carotid Atherosclerosis
|
Kommavarapu, Harshavardhini |
|
|
17 |
4S |
p. e36 |
artikel |
13 |
Cardioprotection from a Silent Syndrome: Effect of Gilbert's Syndrome on Cardiovascular Disease in Patients with Familial Hypercholesteremia
|
Brown, Debra |
|
|
17 |
4S |
p. e29 |
artikel |
14 |
Case Report - Lysosomal Acid Lipase Deficiency - A Rare Cardiometabolic Disease and a NAFLD Mimic
|
Vedamurthy, Deepak |
|
|
17 |
4S |
p. e21-e22 |
artikel |
15 |
Characteristics Associated with Inclisiran Initiation in Outpatient Physician Clinics
|
Ballantyne, Christie M |
|
|
17 |
4S |
p. e33-e34 |
artikel |
16 |
Characteristics of Individuals with Dyslipidemia Referred for Genetic Screening for Genetic Lipid Disorders
|
Vartak, Natasha |
|
|
17 |
4S |
p. e22-e23 |
artikel |
17 |
Characteristics of Patients Initiating Inclisiran in the Real World: A Retrospective Analysis of a US Database
|
Niu, Xiaoli |
|
|
17 |
4S |
p. e57-e58 |
artikel |
18 |
† Cholesterol Efflux Capacity in Patients with or without Type 2 Diabetes Mellitus: A Meta-Analysis
|
Chi, Gerald |
|
|
17 |
4S |
p. e33 |
artikel |
19 |
Clinical Vignette - Keto Diet-Induced Dyslipidemia and Lean Mass Hyper-Responders
|
Vedamurthy, Deepak |
|
|
17 |
4S |
p. e7-e8 |
artikel |
20 |
⁎ Closing The Gap: A Quality Improvement Initiative to Educate House Staff and Faculty on Guideline Directed Lipid Lowering Therapy
|
Weintraub, Spencer Frederick |
|
|
17 |
4S |
p. e2 |
artikel |
21 |
CME Activity Highlights the Improvement in Clinician's Knowledge and Competence about Treatment Choices for LDL-C Lowering Post-MI
|
Agarwal, Neha |
|
|
17 |
4S |
p. e61 |
artikel |
22 |
Coronary Artery Spasm: Risk Factors and in-Hospital Outcomes
|
Xi, Qianlan |
|
|
17 |
4S |
p. e18 |
artikel |
23 |
Coronary Computed Tomographic Angiography as the Initial Gatekeeper Modality to Identify and Assess the Severity of Atherosclerotic Coronary Artery Disease
|
Alam, Loba |
|
|
17 |
4S |
p. e34-e36 |
artikel |
24 |
Diagnosis and Management of Familial Dysbetalipoproteinemia in a Patient with Apo E2/E2 Genotype
|
Golwala, Sohil |
|
|
17 |
4S |
p. e28-e29 |
artikel |
25 |
Direct Contact of At-Risk Relatives in the United States Identifies Familial Hypercholesterolemia Cases
|
Morgan, Kelly M |
|
|
17 |
4S |
p. e23-e24 |
artikel |
26 |
Dried Blood Spot Testing for Cardiovascular Risk Assessment
|
Lang, Maxine |
|
|
17 |
4S |
p. e19 |
artikel |
27 |
Effect of Dexamethasone on Modulating Lp(a) Levels in COVID-19 Pneumonia
|
Kukuc, Laura Grace |
|
|
17 |
4S |
p. e6-e7 |
artikel |
28 |
† Efficacy and Safety of Evinacumab in Pediatric Patients with Homozygous Familial Hypercholesterolemia
|
Wiegman, Albert |
|
|
17 |
4S |
p. e43-e44 |
artikel |
29 |
Equitable Access to Screening and Lipid-Lowering Therapies in a Large Academic Center after Educational Interventions
|
Umer, Muhammad |
|
|
17 |
4S |
p. e14-e15 |
artikel |
30 |
† Evaluating the Residual Risk of Recurrent Cardiovascular Events in Contemporary Cardiovascular Outcomes Trials
|
Serge, Korjian |
|
|
17 |
4S |
p. e1-e2 |
artikel |
31 |
Evaluation of Lipid, Lipoprotein, and Apolipoprotein Analysis by Nuclear Magnetic Resonance
|
Fernandes, Marianna |
|
|
17 |
4S |
p. e18-e19 |
artikel |
32 |
Evinacumab Reduces US Apheresis Eligibility in Patients with Homozygous Familial Hypercholesterolemia
|
Raal, Fredrick J |
|
|
17 |
4S |
p. e44 |
artikel |
33 |
Exploring Prevalence of Statin Intolerance in Patients on LDL-Lowering Therapy Using Epic
|
Baecher, Naz |
|
|
17 |
4S |
p. e21 |
artikel |
34 |
Familial LCAT (Lecithin: Cholesterol Acyltransferase) Deficiency: A Case Report
|
Alfaro, Gregory |
|
|
17 |
4S |
p. e25-e26 |
artikel |
35 |
Following a Hunch: Diagnosis of Familial Hypercholesterolemia in a Patient with Severe Hypertriglyceridemia
|
Modarressi, Taher |
|
|
17 |
4S |
p. e11 |
artikel |
36 |
Genetic and Metabolic Determinants of Lipoprotein(a)
|
Stewart, Sarah L |
|
|
17 |
4S |
p. e5-e6 |
artikel |
37 |
Genetic Variants in Patients with Persistent, Severe Hypertriglyceridemia
|
Bernstein, Donna L. |
|
|
17 |
4S |
p. e32-e33 |
artikel |
38 |
† Higher Cardiovascular Event Rates for High-Risk Americans Who Did Not Meet 2018 Multidisciplinary Guideline on the Management of Blood Cholesterol Thresholds
|
Myers, Kelly D |
|
|
17 |
4S |
p. e5 |
artikel |
39 |
Improvement in Cognitive Function and Reducing the Risk of Developing Cardiovascular Events/ Stroke in Homocysteinemia
|
Gabrah, Kirollos |
|
|
17 |
4S |
p. e27-e28 |
artikel |
40 |
⁎ Incidental Coronary Calcium on Non-Gated CT Scans of the Chest: A Stepwise Approach to Addressing Underreporting and Implementing Deep Learning
|
Grant, Jelani K. |
|
|
17 |
4S |
p. e37-e38 |
artikel |
41 |
Incident Type 2 Diabetes (T2D) Following Statin Initiation in Youth
|
Webster, Gabriella Elizabeth Zaruba |
|
|
17 |
4S |
p. e41-e42 |
artikel |
42 |
† Investigating Hepatocyte Cholesterol Uptake Ex Vivo Following CSL112 (Apolipoprotein A-I [Human]) Infusion in Post Myocardial Infarction Patients
|
Velkoska, Elena |
|
|
17 |
4S |
p. e34 |
artikel |
43 |
Lifestyle Intervention in Primary Care Patients with Metabolic Syndrome
|
Shackelford, Sommer |
|
|
17 |
4S |
p. e49 |
artikel |
44 |
Lipid Goals Achievement in Secondary Cardiovascular Prevention: Predictors of Success in a Large Multicentre Cohort Study in Greece
|
Paparodis, Rodis D. |
|
|
17 |
4S |
p. e46 |
artikel |
45 |
Lipid Goals Achievement in Secondary Cardiovascular Prevention: Predictors of Success in a Large Multicentre Cohort Study in Greece
|
Paparodis, Rodis D. |
|
|
17 |
4S |
p. e47 |
artikel |
46 |
Lipid lowering Effect of Dapagliflozin Alone versus Dapagliflozin- Saxagliptin Combination in Type 2 Diabetes (T2DM) Subjects
|
Sen, Sabyasachi |
|
|
17 |
4S |
p. e48 |
artikel |
47 |
Lipoprotein(a): Mirroring Familial Hypercholesterolemia
|
Parvathinathan, Lakshmi |
|
|
17 |
4S |
p. e10 |
artikel |
48 |
Lipoprotein X - In Graft vs. Host Disease
|
Vedamurthy, Deepak |
|
|
17 |
4S |
p. e10-e11 |
artikel |
49 |
† Lomitapide Hepatic Safety: A Long-Term Retrospective Analysis in Patients with Homozygous Familial Hypercholesterolaemia
|
Larrey, Dominique |
|
|
17 |
4S |
p. e31 |
artikel |
50 |
Long-Term Efficacy and Safety of Twice-Yearly Inclisiran in Patients with ASCVD and Elevated LDL-C: A Post-Hoc Analysis of ORION-3, a 4-year Open-Label Extension Study
|
Wright, Scott R. |
|
|
17 |
4S |
p. e56-e57 |
artikel |
51 |
LP-PLA2 is more Effective at Predicting Elevated CV Risk in Law Enforcement Officers as Compared to Framingham Risk or Coronary Calcium Scoring
|
Sheinberg, Jon |
|
|
17 |
4S |
p. e38 |
artikel |
52 |
Management of Dyslipidemia in a Patient with Cerebral Cavernoma
|
Golwala, Sohil |
|
|
17 |
4S |
p. e40-e41 |
artikel |
53 |
Medications Are Not Enough: Interdisciplinary Treatment of Familial Chylomicronemia Syndrome in Pregnancy
|
Klahr, Rebecca |
|
|
17 |
4S |
p. e42-e43 |
artikel |
54 |
Nuclear Magnetic Resonance Analysis of Serum Amino Acids, General Health Parameters, and Keto-Acids
|
Flowers, Sarah E |
|
|
17 |
4S |
p. e50-e51 |
artikel |
55 |
Partial Lysosomal Acid Lipase Deficiency (LAL-D) in Fatty Liver Disease: A Future Role in Preventing Atherosclerosis?
|
Subramanyam, Pritha |
|
|
17 |
4S |
p. e40 |
artikel |
56 |
Patients with Diabetes Mellitus and Dyslipidemia Affected by Non-Alcoholic Fatty Liver Disease have higher Mortality and Worse Clinical Outcomes, Nation-Wide Study
|
Khokhlov, Leonid |
|
|
17 |
4S |
p. e53 |
artikel |
57 |
Patients with Dyslipidemia and Chronic Kidney Disease Affected by Non-Alcoholic Fatty Liver Disease Have higher Mortality and Worse Clinical Outcomes, Nation-Wide Study
|
Khokhlov, Leonid |
|
|
17 |
4S |
p. e20 |
artikel |
58 |
Patients with Dyslipidemia and Heart Failure Affected by Non-Alcoholic Fatty Liver Disease Have higher Mortality and Worse Clinical Outcomes, Nation-Wide Study
|
Khokhlov, Leonid |
|
|
17 |
4S |
p. e20-e21 |
artikel |
59 |
Patients with Familial Hypercholesterolemia with Non-Alcoholic Fatty Liver Disease Have Worse Clinical Outcomes, Nation-Wide Study
|
Khokhlov, Leonid |
|
|
17 |
4S |
p. e55 |
artikel |
60 |
† Pegozafermin for the Treatment of Severe Hypertriglyceridemia, a Randomized, Double-blind, Placebo-controlled Phase 2 Trial (ENTRIGUE STUDY)
|
Bhatt, Deepak L |
|
|
17 |
4S |
p. e47-e48 |
artikel |
61 |
Pegylated-Asparaginase Induced Severe Hypertriglyceridemia in an Adult with Acute B-cell Lymphoblastic Leukemia
|
Acevedo-Mendez, Bernardo Andres |
|
|
17 |
4S |
p. e8 |
artikel |
62 |
† Pharmacokinetics of Mibavademab in Healthy Participants: Results from a Randomized, Phase 1, Two-Part, First-in-Human Study
|
Mendell, Jeanne |
|
|
17 |
4S |
p. e58 |
artikel |
63 |
Predictors of All-Cause Mortality in Heterozygous Familial Hypercholesterolemia: A Multinational Prospective Study
|
Baass, Alexis Wilfrid |
|
|
17 |
4S |
p. e26-e27 |
artikel |
64 |
† Prevalence and Clinical Outcomes of Lipodystrophy: Cross-Sectional Analyses of a US National Cohort
|
Yang, Seonkyeong |
|
|
17 |
4S |
p. e58-e59 |
artikel |
65 |
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease
|
Upadhyaya, Bhavana |
|
|
17 |
4S |
p. e17-e18 |
artikel |
66 |
Primary Prevention of Stroke is Strongly Correlated with Low-Density-Lipoprotein Cholesterol Reduction: A Meta-Regression Analysis
|
Ghosal, Samit |
|
|
17 |
4S |
p. e38-e39 |
artikel |
67 |
⁎ Racial Disparities in Access to Coronary Calcium Scoring and Downstream Cardiovascular Care and Events
|
Umer, Muhammad |
|
|
17 |
4S |
p. e14 |
artikel |
68 |
Rationale and Design of the Balance Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Olezarsen in Patients with Familial Chylomicronemia Syndrome
|
Karwatowska-Prokopczuk, Ewa |
|
|
17 |
4S |
p. e45 |
artikel |
69 |
Refractory Hypercholesterolemia in Heterozygous Familial Hypercholesterolemia Treated with Evinacumab
|
Haynes, Tiffany |
|
|
17 |
4S |
p. e26 |
artikel |
70 |
Severe Heterozygous Familial Hypercholesterolemia and Elevated Lipoprotein(a): A Double Whammy
|
Parvathinathan, Lakshmi |
|
|
17 |
4S |
p. e8-e9 |
artikel |
71 |
Statins and the Risk of Breast, Lung, Colorectal, and Prostate Cancers
|
Vorla, Mounica |
|
|
17 |
4S |
p. e59-e60 |
artikel |
72 |
Statin Use After ICH; Is It Safe? A Common but Complex Clinical Scenario under Current Investigation
|
Ambrosino, Maxwell |
|
|
17 |
4S |
p. e9-e10 |
artikel |
73 |
Supine Blood Pressure, a Better Predictor of Target Organ Damage than Sitting Blood Pressure
|
Xi, Qianlan |
|
|
17 |
4S |
p. e13-e14 |
artikel |
74 |
† Survival into the Eleventh Decade in Persons Receiving Statin Therapy
|
Feeman Jr, William E. |
|
|
17 |
4S |
p. e12 |
artikel |
75 |
The Healthy Eating Assessment Tool (HEAT): A Aimplified 10-Point Assessment of CHILD-2 Dietary Compliance for Children with Dyslipidemia
|
Wong, Jonathan Peter |
|
|
17 |
4S |
p. e42 |
artikel |
76 |
The Outcome of Percutaneous Coronary Intervention in Patients with Familial Hypercholesterolemia: A Nationwide Analysis
|
Amoah, Joseph Kofi |
|
|
17 |
4S |
p. e30 |
artikel |
77 |
The Outcome of Percutaneous Coronary Intervention in Patients with Metabolic Syndrome: A Nationwide Analysis
|
Amoah, Joseph Kofi |
|
|
17 |
4S |
p. e52-e53 |
artikel |
78 |
The Outcome of Percutaneous Coronary Intervention in Prediabetes Patients: A Nationwide Analysis
|
Amoah, Joseph Kofi |
|
|
17 |
4S |
p. e52 |
artikel |
79 |
The Prediction and Prevention of Diabetes Mellitus
|
Schaefer, Ernst J |
|
|
17 |
4S |
p. e51 |
artikel |
80 |
† The Vast Majority of High- and Very-High Risk Hypercholesterolemia Patients Never Reach below LDL-C Thresholds in the 2018 ACC/AHA Guidelines
|
Wilemon, Katherine A |
|
|
17 |
4S |
p. e4-e5 |
artikel |
81 |
Timing of PCSK9i Initiation and Its Relationship with Clinical Outcomes in US Patients with Prior Cardiovascular Events: A Claims Database Analysis
|
Martinez, Laura |
|
|
17 |
4S |
p. e44-e45 |
artikel |
82 |
Treatment Target Achievement in Patients with Familial Hypercholesterolemia: A Real-World Descriptive Study
|
Baass, Alexis Wilfrid |
|
|
17 |
4S |
p. e4 |
artikel |
83 |
Trends in Lipoprotein(a) Testing at the University of Pennsylvania Health Systems from 2012-2021
|
Bajaj, Archna |
|
|
17 |
4S |
p. e3-e4 |
artikel |
84 |
† Triglyceride Patterns among Patients in US Clinical Practice
|
Kutrieb, Emily |
|
|
17 |
4S |
p. e60-e61 |
artikel |
85 |
Underutilization of Guideline-Recommended Genetic Testing to Diagnose Familial Hypercholesterolemia in a Large, Real-world Cohort
|
Ward, Andrew |
|
|
17 |
4S |
p. e31-e32 |
artikel |
86 |
Usefulness of the ApoB Quick Diagnosis App in the Diagnosis of Suspected Familial Chylomicronemia Syndrome
|
Kukuc, Laura Grace |
|
|
17 |
4S |
p. e27 |
artikel |
87 |
^† Using Healthcare Claims Data and Machine Learning to Identify Health Disparities for Individuals with Familial Hypercholesterolemia
|
Ahmad, Zahid |
|
|
17 |
4S |
p. e16 |
artikel |
88 |
Using Virtual Reality and Other Immersive Tools to increase HCPs Ability to Differentially Diagnose and Manage FH
|
Welch, Lauren |
|
|
17 |
4S |
p. e45-e46 |
artikel |
89 |
*! Very-High-Risk Atherosclerotic Cardiovascular Disease Status Among Patients with CAC >1000: Implications for Intensive Lipid-Lowering Therapy
|
Razavi, Alexander C. |
|
|
17 |
4S |
p. e12-e13 |
artikel |